D-1058-2020 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-1058-2020 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Mar 11, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Presence of dark brown discoloration on edges of tablets The recall status is terminated (terminated Jun 10, 2020). Affected quantity: 89,376 90-count bottles.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Mar 11, 2020
Termination Date
Jun 10, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
89,376 90-count bottles

Product description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90

Reason for recall

CGMP Deviations: Presence of dark brown discoloration on edges of tablets

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot # PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1058-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1058-2020. Report a data issue: hello@regdatalab.com.